Case series on placenta accreta spectrum disorder and its management

Maya Kumari; Amrita D. Patel; Vishrut Mashruwala

doi:10.18203/2320-1770.ijrcog20241781

Authors

Maya Kumari Department of Obstetrics and Gynecology, B. J. Medical College, Ahmedabad, Gujarat, India
Amrita D. Patel Department of Obstetrics and Gynecology, B. J. Medical College, Ahmedabad, Gujarat, India
Vishrut Mashruwala Department of Obstetrics and Gynecology, B. J. Medical College, Ahmedabad, Gujarat, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20241781

Keywords:

Placenta accreta spectrum, Obstetrics hemorrhage, One step uterine conservative surgery

Abstract

Placenta accreta spectrum (PAS) is a potentially life-threatening obstetric condition that requires a multidisciplinary approach to management. The main complication of PAS is due to it’s massive obstetric haemorrhage which leads to maternal morbidity and mortality. The incidence of placenta accreta spectrum increases day by day due to an alarming increase in caesarean section rates. Depending on the range of invasiveness, The Placenta accreta spectrum is classified as placenta accreta, placenta increta and placenta percreta. We report here a series of 5 cases of placenta accreta spectrum and their management at our centre. With all due pre-op preparedness and anticipation of complications. All 5 cases had good maternal and fetal outcome. In 3 cases hysterectomy was required and 2 cases uterus could be preserved.

Metrics

Metrics Loading ...

References

Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005;192:1458-61 .

Committee on Obstetric Practice American College of Obstetricians and Gynecologists. ACOG committee opinion. Placenta accreta. Number 266, January 2002. International Journal of Gynecology and Obstetrics. 2002;77(1):77-8.

Read JA, Cotton DB , Miller FC . Placenta accreta: changing clinical aspects and outcome. Obstet Gynecol. 1980;56:31-4.

Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol. 1997;177:210-4 .

Mogos MF, Salemi JL, Ashley M, Whiteman VE, Salihu HM. Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-associated costs, 1998-2011. J Matern Fetal Neonatal Med. 2016;29:1077-82.

Calí G, Timor-Tritsch IE, Forlani F, Palacios-Jaraquemada J, Monteagudo A, Agten AK, et al. Value of first-trimester ultrasound in prediction of third-trimester sonographic stage of placenta accreta spectrum disorder and surgical outcome Ultrasound Obstet Gynecol. 2020;55(4):450-9.

Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Obstet Gynecol. 2006;107:1226-32.

Cahill AG, Beigi R, Heine RP, Silver RM, Wax JR. Placenta Accreta Spectrum. Am J Obstet Gynecol. 2016(6):2-16.

Palacios-Jaraquemada JM. Diagnosis and management of placenta accreta. Best Pract Res Clin Obstet Gynecol. 2008;22:1133-48.

Cho JH, Jun HS, Lee CN. Hemostatic suturing technique for uterine bleeding during cesarean delivery. Obstet Gynecol. 2000;96:129-31.

Chandraharan E, Rao S, Belli AM, Arulkumaran S. The Triple-P procedure as a conservative surgical alternative to peripartum hysterectomy for placenta percreta. Int J Gynaecol Obstet. 2012;117:191-4.

Su HW, Yi YC, Tseng JJ. Maternal outcome after conservative management of abnormally invasive placenta. Taiwan J Obstet Gynecol. 2017;56:353-7.

Patel A. Dr Sapna Shah. Placenta Accreta spectrum disorders: A detailed insight. Gujarat University, India. 2022:110-115.